Phil Prendergast (Labour)

If the scheme seeks to influence demand and patterns of prescription in the GMS, does she envisage a reduction in the amount saved other than the aforementioned €2 million per month? I refer to the intention to dictate prescribing practices or perhaps generic substitutions.